1,405
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Integrated bioinformatics analysis of miRNA expression in osteosarcoma

, , &
Pages 936-943 | Received 23 Apr 2016, Accepted 28 May 2016, Published online: 17 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Han Zhang, Guanhong Chen, Xiajie Lyu, Chun Rong, Yingzhen Wang, Ying Xu & Chengyu Lyu. (2021) A Novel Predictive Model Associated with Osteosarcoma Metastasis. Cancer Management and Research 13, pages 8411-8423.
Read now
Xuesen Li, Na Li, Qinghui Niu, Haibin Zhu, Zhijie Wang & Qingxian Hou. (2020) Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma. OncoTargets and Therapy 13, pages 1851-1857.
Read now
Zhaozhou Ren, Ming He, Tao Shen, Kejia Wang, Qingjie Meng, Xiangxu Chen, Long Zhou, Yanshuo Han, Chao Ji, Shengnan Liu & Qin Fu. (2020) MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression. Cancer Biology & Therapy 21:3, pages 231-240.
Read now
Hu Zhao, Wei Zhang, Xiaofeng Lai, Hehuan Zhu, Shenhang Zhang, Weizhen Wu, Shuiliang Wang, Minying Tang, Zhen Deng & Jianming Tan. (2019) MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 278-289.
Read now
Zhigang Qin, Xin Wei, Ning Jin, Yao Wang, Rui Zhao, Yangqing Hu, Weijian Yan, Junke Li & Qiaoling Zhou. (2018) MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1920-1925.
Read now
Li-Pei Wu, Jian Wu, Anquan Shang, Man Yang, Ling-Ling Li, Jing Yu, Lei-Rong Xu, Chun-Bing Wang, Wei-Wei Wang, Jian-Jun Zhu & Wen-Ying Lu. (2018) miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 159-167.
Read now
Neda Shajari, Sadaf Davudian, Tohid Kazemi, Behzad Mansoori, Shima Salehi, Vahid Khaze Shahgoli, Dariush Shanehbandi, Ali Mohammadi, Pascal H. G. Duijf & Behzad Baradaran. (2018) Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1495-1504.
Read now

Articles from other publishers (14)

Foroogh Hosseini, Dariush Shanehbandi, Jafar Soleimanpour, Bahman Yousefi & Forough Alemi. (2022) Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin. Drug Research 72:06, pages 312-318.
Crossref
Luis Alberto Bravo Vázquez, Mariana Yunuen Moreno Becerril, Erick Octavio Mora Hernández, Gabriela García de León Carmona, María Emilia Aguirre Padilla, Samik Chakraborty, Anindya Bandyopadhyay & Sujay Paul. (2021) The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential. Molecules 27:1, pages 211.
Crossref
Jiao Guo, Yongda Liu & Ping Zhao. (2021) Bioinformatic Analysis Identified Potentially Prognostic Long Noncoding RNAs and MicroRNAs for Gastric Cancer. BioMed Research International 2021, pages 1-14.
Crossref
Wei Hong, Songsong Li, Yueqin Cai, Tingting Zhang, Qingrou Yang, Beihui He, Jianshun Yu & Zhiyun Chen. (2020) The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against‐Non-Alcoholic Steatohepatitis. Frontiers in Pharmacology 11.
Crossref
Zaizai Cao, Yu Guo, Yinjie Ao & Shuihong Zhou. (2020) Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach. Future Oncology 16:33, pages 2723-2734.
Crossref
Ping-rong Zhang, Jing Ren, Jian-shan Wan, Rong Sun & Ying Li. (2020) Circular RNA hsa_circ_0002052 promotes osteosarcoma via modulating miR-382/STX6 axis. Human Cell 33:3, pages 810-818.
Crossref
Shenglong Li, Yi Pei, Wei Wang, Fei Liu, Ke Zheng & Xiaojing Zhang. (2020) Extracellular nanovesicles‐transmitted circular RNA has_circ_0000190 suppresses osteosarcoma progression. Journal of Cellular and Molecular Medicine 24:3, pages 2202-2214.
Crossref
Ming He, Peng Shen, Chuang Qiu & Jiashi Wang. (2019) miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging 11:15.
Crossref
Leimarembi Devi Naorem, Mathavan Muthaiyan & Amouda Venkatesan. (2018) Identification of dysregulated miRNAs in triple negative breast cancer: A meta‐analysis approach. Journal of Cellular Physiology 234:7, pages 11768-11779.
Crossref
Yingyong Wu & Jinyun Peng. (2019) miR-27b Targets HOXB8 to Inhibit Malignant Behaviors of Osteosarcoma. Technology in Cancer Research & Treatment 18, pages 153303381987079.
Crossref
Xiao Ma, Dan Li, Yan Gao & Cheng Liu. (2019) miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66. Technology in Cancer Research & Treatment 18, pages 153303381987020.
Crossref
Wang Jiashi, Qiu Chuang, Zhang Zhenjun, Wang Guangbin, Li Bin & He Ming. (2018) MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression. Aging 10:6, pages 1294-1305.
Crossref
Biao Zhong, Shang Guo, Wei Zhang, Chi Zhang, Yukai Wang & Changqing Zhang. (2017) Bioinformatics prediction of miR-30a targets and its inhibition of cell proliferation of osteosarcoma by up-regulating the expression of PTEN. BMC Medical Genomics 10:1.
Crossref
Chenyang Song, Wenge Liu & Jiandong Li. (2017) USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial–mesenchymal transition through stabilizing SMAD4. Tumor Biology 39:7, pages 101042831771713.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.